This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
- Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy
- Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
- Enhancement of 211At Uptake via the Sodium Iodide Symporter by the Addition of Ascorbic Acid in Targeted {alpha}-Therapy of Thyroid Cancer
- 124I PET Assessment of Response of Bone Metastases to Initial Radioiodine Treatment of Differentiated Thyroid Cancer
- Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT
- Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging
- Radioiodine Therapy for Thyroid Cancer in the Era of Risk Stratification and Alternative Targeted Therapies
- Thyroid Carcinoma
- The success rate of I-131 ablation in differentiated thyroid cancer: comparison of uptake-related and fixed-dose strategies
- Comparison of Outcomes After 123I Versus 131I Preablation Imaging Before Radioiodine Ablation in Differentiated Thyroid Carcinoma
- Role of Radioactive Iodine for Adjuvant Therapy and Treatment of Metastases
- Ablation of the Thyroid Remnant and I-131 Dose in Differentiated Thyroid Cancer: A Meta-Analysis Revisited
- A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow-up
- Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma.
- rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
- The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma
- Impact of 131I Diagnostic Activities on the Biokinetics of Thyroid Remnants
- Increasing Efficacy and Safety of Treatments of Patients with Well-Differentiated Thyroid Carcinoma by Measuring Body Retentions of 131I
- A Retrospective Review of the Effectiveness of Recombinant Human TSH as a Preparation for Radioiodine Thyroid Remnant Ablation
- Advances in radionuclide imaging: radionuclide imaging as a guide to therapy
- Improved Prediction of Therapeutic Absorbed Doses of Radioiodine in the Treatment of Thyroid Carcinoma